DermaSensor
Share
America’s first FDA-cleared, AI-powered skin cancer detection device. Clinically proven and trusted by Primary Care Physicians.
07/07/2026
DermaSensor at the World Health Expo Conference.
Our CEO, Cody Simmons, joined the panel “Cracking the Enterprise Health System: How to Sell and Scale in 2026,” sharing insights on what it takes to bring innovative healthcare technology into enterprise health systems.
Proud to be part of conversations shaping the future of health innovation, AI-powered tools, and better access to advanced care.
Learn more about DermaSensor at dermasensor.com.
06/18/2026
Award-winning innovation is only meaningful when it creates real impact in clinical practice.
From recognition by TIME, SXSW, Inc., and The Digital Health Hub Foundation to real-world use in patient care, DermaSensor™ continues to help support the future of skin cancer assessments with AI-powered, non-invasive technology.
Designed for modern healthcare workflows. Built to support more confident clinical evaluations at the point of care.
Learn more about integrating DermaSensor™ into your practice at dermasensor.com.
Primary care physicians are often the first clinicians patients turn to when they notice a suspicious skin lesion.
That’s why DermaSensor™ is focused on bringing innovative, AI-powered technology into everyday clinical practice to help support earlier skin cancer assessments and more informed evaluations at the point of care.
Chief Commercial Officer Carolyn Walsh shares how DermaSensor™ is working to help improve skin cancer care by supporting the providers on the front lines of patient care. 🔬
Looking to enhance skin cancer assessment in your practice? Learn more about DermaSensor™ at dermasensor.com.
Click here to claim your Sponsored Listing.
Category
Contact the practice
Telephone
Website
Address
Miami, FL
33130
